Author:
Fang Ying,Xu Changyan,Fu Yan
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Mezzanzanica D. Ovarian cancer: a molecularly insidious disease. Chin J Cancer. 2015;34:1–3.
2. Gasiorowska E, Michalak M, Warchoł W, Lemańska A, Jasiński P, Spaczyński M, et al. Clinical application of HE4 and CA125 in ovarian cancer type I and type II detection and differential diagnosis. Ginekol Pol. 2015;86:88–93.
3. Ahmad B, Nawaz S, Ali S, Bashir S, Mahmood N, Gul B. Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. Asian Pac J Cancer Prev. 2015;16:185–9.
4. Liu X, Gao Y, Lu Y, Zhang J, Li L, Yin F. Oncogenes associated with drug resistance in ovarian cancer. J Cancer Res Clin Oncol. 2015;141:381–95.
5. Zou J, Yin F, Wang Q, Zhang W, Li L. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer. Int J Clin Exp Pathol. 2015;8:6847–58.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献